Skip to main content

Search

Site

Search results

3 SEARCH RESULTS FOR

gvhd

Not finding what you're looking for? Visit Janssen in your country.
PAGE 1 OF 1

Apr 04, 2017 United States GVHD is a life-threatening condition with limited treatment options Milestone highlights the potential benefit of ibrutinib beyond blood cancers RARITAN, NJ, April 4, 2017 – Janssen Research & Development, LLC announced ...

Dec 06, 2016 United States Data at the American Society of Hematology Annual Meeting highlight potential role of ibrutinib therapy beyond hematologic cancers cGVHD is a major cause of stem cell or bone marrow transplant-related illness, death and ...

Aug 02, 2017 United States The approval provides an important new treatment option for adults living with debilitating and potentially life-threatening condition This is the first indication for IMBRUVICA outside of oncology and its sixth U.S. indication ...

3 SEARCH RESULTS FOR

gvhd

Not finding what you're looking for? Visit Janssen in your country.
PAGE 1 OF 1